Zhejiang Medicine Co., Ltd.

¥11.14As of Sun 8 Nov 2026, 12:00 UTC
SSE:600216Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (0.44%)
Div yield 2.51%
ROE 3.85%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.42
PE TTM 16.92
TSR TTM (21.66%)
Mkt cap ¥10.56B
ROIC 5.29%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥13
20.45%
(31.11%)
Sell 1|0|1|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.11
0.11
0.10
11.22%
6.46%
2.51%
(10.56%)
Revenue¥M
541.9
562.5
565.4
584.1
1.89%
4.11%
5.35%
5.65%
Peers (US$1.583B)
Cap (US$)
PE
1.581B
—
1.576B
42.18x
Capital
TTM
5Y
10Y
Leveragex
0.993
0.308
0.323
EBIT/Intx
0.230
0.940
0.863
Own earn%
(1243.18)
117.36
82.63
Sh yield%
45.42
41.25
41.60
Owners
Insiders/Inst%
1.70
75.02
Short interest%
5.97
SBC / revenue%
1.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
17–24
$1 testx
—
Incr. ROIC%
6